Bridgeway Capital Management, LLC Oric Pharmaceuticals, Inc. Transaction History

Bridgeway Capital Management, LLC

  • $4.44 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$5.41 - $9.43 $141,742 - $247,066
-26,200 Reduced 53.8%
22,500 $206,000
Q3 2023

Nov 14, 2023
SELL
$6.05 - $9.28 $341,825 - $524,320
-56,500 Reduced 53.71%
48,700 $294,000
Q4 2022

Feb 14, 2023
BUY
$2.41 - $5.89 $97,605 - $238,545
40,500 Added 62.6%
105,200 $619,000
Q3 2022

Nov 14, 2022
BUY
$3.15 - $5.24 $203,805 - $339,028
64,700 New
64,700 $207,000

Others Institutions Holding ORIC

# of Institutions
124
Shares Held
66.6M
Call Options Held
7.8K
Put Options Held
700
View Full List

About Oric Pharmaceuticals, Inc.

ORIC Quotes by TradingView
  • Ticker ORIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,576,700
  • Market Cap $336M
  • Description
  • ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...
More about ORIC
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email